A carregar...

Inhibition of vaccinia virus replication by nitazoxanide

Nitazoxanide (NTZ) is an FDA-approved anti-protozoal drug that inhibits several bacteria and viruses as well. However, its effect on poxviruses is unknown. Therefore, we investigated the impact of NTZ on vaccinia virus (VACV). We found that NTZ inhibits VACV production with an EC(50) of ~2μM, a pote...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Virology
Main Authors: Hickson, Sarah E., Margineantu, Daciana, Hockenbery, David M., Simon, Julian A., Geballe, Adam P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5929478/
https://ncbi.nlm.nih.gov/pubmed/29625403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2018.03.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!